mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

By Prajapati H. J.   Spivey J. R.   Hanish S. I.   El-Rayes B. F.   Kauh J. S.   Chen Z.   Kim H. S.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 965-973

Oxford University Press

Access to resources Recommend Favorite

Three (3) Cases of Advanced HepatocellularCarcinoma (HCC) Treated Successfully by Transcatheter Arterial Chemoembolization (TACE) Using Lipiodol and a Fine Powder Formulated Cisplatin (DDPH)

By Kasai Kazuhiro   Kuroda Hidekatsu   Ushio Akira   Miyamoto Yasuhiro   Sawara Kei   Miyasaka Aikio   Takikawa Yasuhiro   Suzuki Kazuyuki  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 479-483

Sunmedia

Access to resources Recommend Favorite

Radiotherapy combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma — a prospective clinical trial

By Cai Ling  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 64-68

Springer Publishing Company

Access to resources Recommend Favorite

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

By Luo Jun  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 413-420

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 929-935

Science Publishers

Access to resources Recommend Favorite